Approval · Notice of Compliance 30429 · 2023
PRO-AAS EC: Notice of Compliance 30429
Issued March 31, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 30429
- Date
- March 31, 2023
- Company
- Pro Doc LimiteeLaval, Quebec, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- ASPIRIN 81 MG (Bayer Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PRO-AAS EC | 02536587 | Approved |
Medicinal ingredients
- ACETYLSALICYLIC ACID 81 MG per TAB